SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Share ownership Shanghai Shyndec Pharmaceutical Co., Ltd.

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-01-21			5-day change	1st Jan Change
10.57 ^CNY	-0.47%		-0.94%	+4.65%

01-13	Shyndec Pharmaceutical's Generic Drug Secures Approval for Antibiotic Consistency Evaluation	MT
12-26	Shyndec Pharmaceutical Gets China Nod for Antipsychotic	MT

Share class: Shanghai Shyndec Pharmaceutical Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,341,172,692	559,857,631 ( 41.74 %)	0	41.74 %

Major shareholders: Shanghai Shyndec Pharmaceutical Co., Ltd.

Name	Equities	%	Valuation
China Southern Asset Management Co., Ltd. 0.4726 %	6,338,400	0.4726 %	9 M ¥
China Asset Management Co., Ltd. 0.3555 %	4,768,410	0.3555 %	7 M ¥
China Merchants Fund Management Co., Ltd. 0.2762 %	3,704,805	0.2762 %	5 M ¥
Fullgoal Fund Management Co., Ltd. 0.1573 %	2,109,800	0.1573 %	3 M ¥
Guolian Fund Management Co. Ltd. 0.157 %	2,106,300	0.157 %	3 M ¥
Huatai-PineBridge Fund Management Co., Ltd. 0.1026 %	1,375,900	0.1026 %	2 M ¥
Tian Hong Asset Management Co., Ltd. 0.0976 %	1,309,000	0.0976 %	2 M ¥
Essence Fund Co., Ltd. 0.09 %	1,207,500	0.09 %	2 M ¥
State Street Global Advisors Ltd. 0.0792 %	1,061,986	0.0792 %	2 M ¥
Wanjia Asset Management Co., Ltd. 0.0377 %	505,700	0.0377 %	730 888 ¥
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	2.1%
Unknown	97.9%

Based on 1000 largest holdings

Geographical origin of shareholders

China	1.97%
United Kingdom	0.08%
Hong Kong	0.02%
Australia	0.02%

Based on 1000 largest holdings

SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Employees

11,472

Sector

Pharmaceuticals

Calendar

03-27 - Q4 2025 Earnings Release

More about the company